Patents by Inventor Justin B. Bartlett

Justin B. Bartlett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKERS FOR PREDICTING THE SENSITIVITY OF CELLS TO IMMUNOMODULATORY COMPOUNDS DURING TREATMENT OF NON-HODGKIN'S LYMPHOMA
    Publication number: 20160153998
    Abstract: Provided herein are the biomarkers for monitoring the treatment by immunomodulatory compounds. The use of biomarkers such as SPARC, p21, and cyclin D1 mRNA or protein levels as biomarkers to predict whether an immunomodulatory compound is likely to be successful in treating certain types of cancer, such as NHL, is also provided. Further, the expression of these genes or proteins can be used to monitor progress of treatment effectiveness and patient compliance in cancer patients that are receiving treatment with immunomodulatory compounds.
    Type: Application
    Filed: November 13, 2015
    Publication date: June 2, 2016
    Inventors: Peter H. SCHAFER, Justin B. BARTLETT, Ling-Hua ZHANG
  • Immunological uses of immunomodulatory compounds for vaccine and anti-infectious disease therapy
    Patent number: 8715677
    Abstract: Methods of enhancing immune response to an immunogen in a subject are disclosed. Also disclosed are methods of reducing the sensitivity to an allergen in a subject. The methods comprise the administration of an immunomodulatory compound in specific dosing regimens that result in enhanced immune response or reduced sensitivity.
    Type: Grant
    Filed: August 31, 2006
    Date of Patent: May 6, 2014
    Assignee: Celgene Corporation
    Inventors: Justin B. Bartlett, George W. Muller, Peter H. Schafer, Christine Galustian, Angus G. Dalgleish, Brendan Meyer
  • IMMUNOLOGICAL USES OF IMMUNOMODULATORY COMPOUNDS FOR VACCINE AND ANTI-INFECTIOUS DISEASE THERAPY
    Publication number: 20120190110
    Abstract: Methods of enhancing immune response to an immunogen in a subject are disclosed. Also disclosed are methods of reducing the sensitivity to an allergen in a subject. The methods comprise the administration of an immunomodulatory compound in specific dosing regimens that result in enhanced immune response or reduced sensitivity.
    Type: Application
    Filed: April 2, 2012
    Publication date: July 26, 2012
    Inventors: Justin B. BARTLETT, George W. Muller, Peter H. Schafer, Christine Galustian, Angus G. Dalgleish, Brendan Meyer
  • Method of Treating Cancer with Immunomodulatory Compounds and IgG
    Publication number: 20100098657
    Abstract: Provided herein relates to the field of cancer and its treatment by administering immunomodulatory compounds in combination with other compounds. In particular, a combination of an immunomodulatory compound and an antibody is provided.
    Type: Application
    Filed: December 22, 2008
    Publication date: April 22, 2010
    Inventors: Peter H. Schafer, Justin B. Bartlett
  • BIOMARKERS FOR PREDICTING THE SENSITIVITY OF CELLS TO IMMUNOMODULATORY COMPOUNDS DURING TREATMENT OF NON-HODGKIN'S LYMPHOMA
    Publication number: 20090148853
    Abstract: Provided herein are the biomarkers for monitoring the treatment by immunomodulatory compounds. The use of biomarkers such as SPARC, p21, and cyclin D1 mRNA or protein levels as biomarkers to predict whether an immunomodulatory compound is likely to be successful in treating certain types of cancer, such as NHL, is also provided. Further, the expression of these genes or proteins can be used to monitor progress of treatment effectiveness and patient compliance in cancer patients that are receiving treatment with immunomodulatory compounds.
    Type: Application
    Filed: December 5, 2008
    Publication date: June 11, 2009
    Inventors: Peter H. Schafer, Justin B. Bartlett, Ling-Hua Zhang